Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)

A fully government-funded human papillomavirus (HPV) vaccination program started in 2007 in Spain (only 11–14-year-old girls). The first of those vaccinated cohorts, with the quadrivalent vaccine (Gardasil), turned 25 years old in 2018, the age at which cervical cancer screening begins in Spain. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez-Aguado, Juan J., Sánchez Torres, Damián Ángel, Martínez Lamela, Esther, Aguión Gálvez, Gema, Sanz Espinosa, Eva, Pérez Quintanilla, Almudena, Martínez-Carrillo, Daniela A., Ramírez Mena, Mar, Coronado Martín, Pluvio J., Zapardiel, Ignacio, de la Fuente-Valero, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952248/
https://www.ncbi.nlm.nih.gov/pubmed/35335019
http://dx.doi.org/10.3390/vaccines10030387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952248/
https://www.ncbi.nlm.nih.gov/pubmed/35335019
http://dx.doi.org/10.3390/vaccines10030387

Ejemplares similares